(CercleFinance.com) – Pfizer announced yesterday a $120 million investment in its plant in the city of Kalamazoo (Michigan, USA), in order to strengthen its production capacities in the United States and develop the production of its anti-inflammatory pill there. -Covid, Paxlovid (either nirmatrelvir tablets and ritonavir tablets).
The investment is expected to generate some 250 highly skilled jobs at the site and will expand the production of Active Pharmaceutical Ingredients (APIs) and Registered Raw Materials (RSMs) used to manufacture nirmatrelvir.
This project is part of Pfizer’s efforts to expand its key biopharmaceutical manufacturing in the United States.
(c) 2022 CercleFinance.com. All rights reserved.
Related posts:
The Top Seven Most Famous Dogs in the World: From Movie Stars to Life-saving Heroes
Knife attack in the university in Hamm: woman in acute danger of life – Ruhr area – news
[경제]Small and medium-sized enterprises "Chinese visa expired"...Government, emergency meeting
Report: Iran conducts espionage activities targeting organizations, media and academic entities in t...
Lee Jae-myung approves the Grain Management Act, the pioneering legislation for public welfare, but ...
Duop Reath sets new career high with 25 points and nine rebounds, Pistons fall to historic NBA losin...
New Mexico Women's Soccer Team Announces 2023 Fall Schedule: Catch All the Home Action at UNM Soccer...
Joseph Ndiaye: The New Boat on Dakar-Gorée Link for Safety and Comfort